NCT03005678View on ClinicalTrials.gov

Denosumab Versus Bisphosphonates (Alendronate) in GIOP

PHASE4CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

November 1, 2019

Study Completion Date

February 1, 2020

Conditions
Osteoporosis
Interventions
DRUG

Denosumab

active treatment group

DRUG

Alendronate

comparator

Trial Locations (1)

000

Department of Medicine, Tuen Mun Hospital, Hong Kong

All Listed Sponsors
lead

Tuen Mun Hospital

OTHER_GOV

NCT03005678 - Denosumab Versus Bisphosphonates (Alendronate) in GIOP | Biotech Hunter | Biotech Hunter